Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
William Guyer, Chief Development Officer of Corcept Therapeutics Inc, sold 16,300 shares of common stock on August 10, 2026.
Summary
- Option exercise/conversion: acquired 16,300 Common Stock at $21.65 ($352,895) on August 10, 2026; holds 20,285 after (Direct).
- Open-market sale: disposed of 11,530 Common Stock at $113.18 ($1,304,933) on August 10, 2026; holds 8,755 after (Direct).
- Open-market sale: disposed of 4,770 Common Stock at $114.04 ($543,957) on August 10, 2026; holds 3,985 after (Direct).
- Option exercise/conversion: disposed of 16,300 Stock Option (right to buy) on August 10, 2026; holds 110,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,848,890 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
William Guyer — Officer (Chief Development Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Option exercise/conversion | Common Stock | 16,300 | $22 | $352.9K | 20,285 |
| 2026-08-10 | Open-market sale | Common Stock | 11,530 | $113 | $1.3M | 8,755 |
| 2026-08-10 | Open-market sale | Common Stock | 4,770 | $114 | $544.0K | 3,985 |
| 2026-08-10 | Option exercise/conversion | Stock Option (right to buy) | 16,300 | — | — | 110,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Option exercise/conversion (16,300 shares) |
| 2026-08-10 | Open-market sale (11,530 shares) |
| 2026-08-10 | Open-market sale (4,770 shares) |
| 2026-08-10 | Option exercise/conversion (16,300 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, William Guyer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.